UBC Enzymes Eliminate Blood Types
- Researchers at the University of British Columbia (UBC) have made a critically important advancement in transplant medicine by developing enzymes capable of converting blood type A to the...
- Currently, blood type compatibility is a major hurdle in organ transplantation.
- Withers, identified and engineered enzymes that effectively remove the A antigens from red blood cells. These enzymes target specific sugar molecules on the surface of the red blood...
“`html
UBC Researchers Develop Enzymes too Convert Blood Type A to Universal Type O
Table of Contents
Published October 4, 2024, at 05:30 AM PDT
The Breakthrough: converting Blood Type A to O
Researchers at the University of British Columbia (UBC) have made a critically important advancement in transplant medicine by developing enzymes capable of converting blood type A to the universal donor type, O. This finding could dramatically increase the availability of organs for transplant, potentially saving countless lives.
Currently, blood type compatibility is a major hurdle in organ transplantation. Type O blood is considered the universal donor because it lacks A and B antigens, meaning it can be safely transfused to individuals with any blood type. though, only about 45% of the population has type O blood, creating a significant shortage of organs for those needing transplants. Type A blood,representing roughly 40% of the population,cannot be directly used in recipients with types B or O.
How the Enzymes Work
The research team, led by Dr. Steve G. Withers, identified and engineered enzymes that effectively remove the A antigens from red blood cells. These enzymes target specific sugar molecules on the surface of the red blood cells, effectively “cleaving” them off and converting the blood to type O.The process is described as highly efficient and specific, minimizing the risk of unintended consequences.
“ said UBC Professor Dr. Steve G. Withers, one of the researchers involved in the study.
The enzymes work by targeting the N-acetylgalactosamine sugar that defines the A antigen. By removing this sugar,the blood cells become indistinguishable from type O cells.
Implications for Organ Transplantation
This breakthrough has the potential to revolutionize organ transplantation. by converting readily available type A organs to type O, the number of suitable organs for recipients could be significantly increased. This is particularly crucial for patients with rare blood types or those waiting for a second transplant.
The following table illustrates the current blood type distribution in the US population and the potential impact of this technology:
| Blood Type | Percentage of Population (US) | Current Organ Availability | potential Availability with Conversion |
|---|---|---|---|
| O | 45% | Limited | Increased |
| A | 40% | Restricted to A recipients | Available to all recipients |
| B | 11% | Limited | increased (if A converted to B is also possible) |
| AB | 4% | Very limited | Increased (if A converted to AB is also possible) |
Next Steps and Future Research
While the initial